LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired aTyr Pharma Inc. ("aTyr†or the "Company†) (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the "Class Period†). aTyr investors have until December 8, 2025 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON YOUR. ...